Tower Research Capital LLC (Trc) Arrowhead Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,484 shares of ARWR stock, worth $87,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,484

Previous 13,793 74.74%

Holding current value

$87,343

Previous $422,000 76.54%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.21 - $39.48 $280,507 - $406,999	-10,309 Reduced 74.74%	3,484 $99,000
Q4 2023 Feb 13, 2024	BUY	$21.2 - $31.03 $151,601 - $221,895	7,151 Added 107.66%	13,793 $422,000
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $57,220 - $78,798	-2,184 Reduced 24.75%	6,642 $178,000
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $58,371 - $96,001	2,320 Added 35.66%	8,826 $314,000
Q1 2023 May 09, 2023	BUY	$23.68 - $38.51 $38,787 - $63,079	1,638 Added 33.65%	6,506 $165,000

Q4 2022 Feb 10, 2023	SELL	$28.0 - $40.56 $291,928 - $422,878	-10,426 Reduced 68.17%	4,868 $197,000
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $212,891 - $347,107	7,185 Added 88.61%	15,294 $505,000
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $146,508 - $266,815	5,272 Added 185.83%	8,109 $285,000
Q1 2022 May 12, 2022	SELL	$39.62 - $69.97 $221,713 - $391,552	-5,596 Reduced 66.36%	2,837 $130,000
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $304,449 - $432,434	-5,241 Reduced 38.33%	8,433 $559,000
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $298,088 - $433,805	5,106 Added 59.59%	13,674 $854,000
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $422,992 - $614,717	-6,806 Reduced 44.27%	8,568 $709,000
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $521,781 - $769,447	8,505 Added 123.82%	15,374 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $82,644 - $161,007	1,886 Added 37.85%	6,869 $527,000
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $679,941 - $1.05 Million	-20,474 Reduced 80.43%	4,983 $214,000
Q2 2020 Aug 13, 2020	BUY	$26.12 - $43.27 $664,936 - $1.1 Million	25,457 New	25,457 $1.1 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $95,706 - $293,823	-4,655 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$28.14 - $73.01 $106,875 - $277,291	-3,798 Reduced 44.93%	4,655 $295,000
Q3 2019 Nov 05, 2019	BUY	$26.26 - $34.86 $211,445 - $280,692	8,052 Added 2007.98%	8,453 $238,000
Q2 2019 Aug 13, 2019	BUY	$17.43 - $28.82 $5,246 - $8,674	301 Added 301.0%	401 $11,000
Q1 2019 May 14, 2019	SELL	$12.05 - $20.18 $17,749 - $29,725	-1,473 Reduced 93.64%	100 $2,000
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $5,724 - $10,500	533 Added 51.25%	1,573 $20,000
Q3 2018 Nov 13, 2018	BUY	$14.0 - $20.3 $14,560 - $21,112	1,040 New	1,040 $20,000
Q1 2018 May 15, 2018	SELL	$3.72 - $7.64 $91,939 - $188,822	-24,715 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.14 - $4.5 $77,605 - $111,217	24,715 New	24,715 $91,000
Q3 2017 Nov 14, 2017	BUY	$1.69 - $4.33 $0 - $0	0	0 $0

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Arrowhead Pharmaceuticals, Inc. Transaction History